首页> 美国卫生研究院文献>Genes >Hybridization Capture-Based Next-Generation Sequencing to Evaluate Coding Sequence and Deep Intronic Mutations in the NF1 Gene
【2h】

Hybridization Capture-Based Next-Generation Sequencing to Evaluate Coding Sequence and Deep Intronic Mutations in the NF1 Gene

机译:基于杂交捕获的下一代测序以评估编码序列和NF1基因中的深度内含子突变。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Neurofibromatosis 1 (NF1) is one of the most common genetic disorders and is caused by mutations in the NF1 gene. NF1 gene mutational analysis presents a considerable challenge because of its large size, existence of highly homologous pseudogenes located throughout the human genome, absence of mutational hotspots, and diversity of mutations types, including deep intronic splicing mutations. We aimed to evaluate the use of hybridization capture-based next-generation sequencing to screen coding and noncoding NF1 regions. Hybridization capture-based next-generation sequencing, with genomic DNA as starting material, was used to sequence the whole NF1 gene (exons and introns) from 11 unrelated individuals and 1 relative, who all had NF1. All of them met the NF1 clinical diagnostic criteria. We showed a mutation detection rate of 91% (10 out of 11). We identified eight recurrent and two novel mutations, which were all confirmed by Sanger methodology. In the Sanger sequencing confirmation, we also included another three relatives with NF1. Splicing alterations accounted for 50% of the mutations. One of them was caused by a deep intronic mutation (c.1260 + 1604A > G). Frameshift truncation and missense mutations corresponded to 30% and 20% of the pathogenic variants, respectively. In conclusion, we show the use of a simple and fast approach to screen, at once, the entire NF1 gene (exons and introns) for different types of pathogenic variations, including the deep intronic splicing mutations.
机译:神经纤维瘤病1(NF1)是最常见的遗传疾病之一,由NF1基因突变引起。 NF1基因突变分析由于其体积大,存在于整个人类基因组中的高度同源假基因,不存在突变热点以及突变类型的多样性(包括深度内含子剪接突变)而面临着巨大挑战。我们旨在评估使用基于杂交捕获的下一代测序技术来筛选编码和非编码NF1区域。以基因组DNA为起始材料的基于杂交捕获的下一代测序技术,用于对来自11个无关个体和1个亲戚的全部NF1基因(外显子和内含子)进行测序。他们都符合NF1临床诊断标准。我们的突变检测率为91%(11个中的10个)。我们确定了8个复发性突变和2个新突变,均已通过Sanger方法学证实。在Sanger测序确认中,我们还包括了另外三个NF1亲戚。剪接改变占突变的50%。其中之一是由深度内含子突变引起的(c.1260 + 1604A> G)。移码截短和错义突变分别对应于30%和20%的致病变异。总之,我们展示了使用一种简单而快速的方法来一次针对不同类型的致病变异(包括深度内含子剪接突变)筛选整个NF1基因(外显子和内含子)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号